{"name":"Oramed, Ltd.","slug":"oramed-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Cohort A: ORMD-0801","genericName":"Cohort A: ORMD-0801","slug":"cohort-a-ormd-0801","indication":"Type 1 diabetes","status":"phase_2"}]}],"pipeline":[{"name":"Cohort A: ORMD-0801","genericName":"Cohort A: ORMD-0801","slug":"cohort-a-ormd-0801","phase":"phase_2","mechanism":"ORMD-0801 is an oral insulin capsule that mimics the natural insulin production process.","indications":["Type 1 diabetes","Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPRzk0MDdDdkdDSjJId1FuSWVxSE5Qem9WNVZ1VkhSTG5RV0ZUN3JGVjBfVU5NOWstdUNyNUx1MHdJU2lUTnE0ZXZ5Zk5KZ2pYejhUUXd6amk3bDFjOFVaMFdOcWpqWGlFczI3NF9Cc0txRVlTbV9tZF9zNnhKMm5seVBIU3h4cTNycEJFTTVyWDBHZm0tUWp0ZUZLN1NLOGJqZ2lYTUF1RFlCeW85Q0NHdm9ZNzg2eU13ckhaVmljaVdvM1VnSVhENjRQQU1WeEpkMllCclBoUzFKamtXLWpUSXphTQ?oc=5","date":"2026-04-02","type":"pipeline","source":"The Globe and Mail","summary":"Oramed Completes Oratech Sale and Strategic Lifeward Financing - The Globe and Mail","headline":"Oramed Completes Oratech Sale and Strategic Lifeward Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFAybEhpcVZwc296TkJsbzRtd3FpOGZsQW5lWGI5X011aVR0SGMyY1l6VlhsRzRkbTNWVGt5dEhNaEZJdFoyLXp2TGVfcThsTHF0eDFfd0psTFVoUkZzLWtMNHBXdFNBTUNzWGlaWnhvTzM0dzdzOEVZ?oc=5","date":"2026-04-02","type":"pipeline","source":"Barchart.com","summary":"ORMP Price History for Oramed Pharma Stock - Barchart.com","headline":"ORMP Price History for Oramed Pharma Stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQYmptMk5PTWFTanJoYnk3WmdPLTl6VHIyMzBVYy1XUHFTbmRjZEpFaW83bVRQTG9wakFzbmZGRW5VbnhidXVoYUFfT2ktLVo5QWdEeElISmlYVnlsc3hTUnc5WlJpSmZWelNWOW9EWGRON0gyTTBnSFltMUw1cUkzakkwN2F2UWhtaW1qY2x2RFAzVlU0Q09zODZQZVlLSXhRUEpDcTQ1ZlBNejlRbXVVR0VVa01jRjY4LTI4R3p6aENxUVRBelBUc1lsdlRYbjdIZnVBUmpKTXdsOTQyRXNxaklIOHM?oc=5","date":"2026-03-27","type":"earnings","source":"MarketBeat","summary":"Oramed Pharmaceuticals (NASDAQ:ORMP) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat","headline":"Oramed Pharmaceuticals (NASDAQ:ORMP) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOLTdtb3Fmb0pIVVJZVTU2Tlk4RTRseDlMNExwblN5ODFYZGpmaXJZejlYOWhjM3ZMVDQ0eXlpbjFJeU5MQWh1S0x1cE9YdUpUMEpkcmxZQk5MSHR6LU5GREI4YVJUc1JPNC0xZnRWX1liQnVwS012Y1luanIxNmJwbTJIQXAyZ1IzaVBQQldWLWtLQ3R6QjdCUUJRamRJbTdHSXhfckktbWF6TUNvRkhpZlhUQzl6dXUxREVLMmVzby1XLUU?oc=5","date":"2026-03-26","type":"earnings","source":"WKYC","summary":"Oramed: Q4 Earnings Snapshot - WKYC","headline":"Oramed: Q4 Earnings Snapshot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNLUxGSVFEUEdxTTVpVzN4MUJ5XzhnNC1JWHVqdW1UZFFIMzJkeUh2YUpXeGtacm9idWRxa1BsQkR0VXpycDVxQ3BWcVI1b09Zc1JsRlU1SG5udm4xZ05rY3lDQWhuamhOWlZESnFjcTM0T2cybXliWWFIeDBUcDN0cnRRTVdaYjNrX2ZXd3liRGxPRHhQYlFmbXpPLTdZQktValRRN1RYYkRSaHJTX05QOTR1eEVoTFUxQU51ZmxqTm5VcGcyUVJrdU5jV1p0d3JkelgwRUoxeTJXbW1VbEE?oc=5","date":"2026-03-26","type":"deal","source":"marketscreener.com","summary":"Tranche Update on Oramed Pharmaceuticals Inc.'s Equity Buyback Plan announced on June 26, 2024. - marketscreener.com","headline":"Tranche Update on Oramed Pharmaceuticals Inc.'s Equity Buyback Plan announced on June 26, 2024.","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-14","type":"pipeline","source":"simplywall.st","summary":"3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st","headline":"3 Promising Penny Stocks With Market Caps Under $200M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQa1l3NUQzWmlvN01nX09nZW10Y3BRdFQtNVhyVm10ZzJhb3B0R2JxUGRxZHZtOTBCX0FvaEVXVzRUTHdQQnY3VUVnZVRZUUw3Ykc4Znc1QmhfdkFSZ0hUaFlFalQ5R0I5YWlpZktGcENpa21Dc1U3V1dJTUs0dlVuNUJqWExkZ1BrZWVBbkMtMk9CNjFtdjZlUw?oc=5","date":"2026-01-13","type":"pipeline","source":"Financial Times","summary":"Oramed and Lifeward Announce Strategic Transaction - Financial Times","headline":"Oramed and Lifeward Announce Strategic Transaction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNa0lLblBtRXZiU21sM1QyTmpJXzdrRl8wYVZBYjgweUxOTjZfX0pQRTZyRXJ6cUxZOF9DaEhvQndoQzFsclRXeUdrRllXa0tKV29od2VkUFFHQTVpYVo0SnhEamZuZDdyWjJKajNRQUdSdExaOFFaaXVvNHhjMzI0a2RwdUlLV2tHd212c0lWUldLZ2Z6cTc0T2l3bEtROWI3d1BnOFBtYl9ZTDVCc1lWRHpZT0FtZVBhNnpjZ0FGUUpEMktNcWF3Yg?oc=5","date":"2025-12-31","type":"pipeline","source":"Investing.com","summary":"Oramed Pharmaceuticals completes $28.5 million warrant repurchase by Scilex - Investing.com","headline":"Oramed Pharmaceuticals completes $28.5 million warrant repurchase by Scilex","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNSE1VZXFTVWV3bjdCWGdVYmFEOHRaTDRQWUdxTW1qRGtzTmVkempCQUppeVE4OEZlOWRjQWJITEYtNml5M2lmOWVJV2hqRUh2X05IeVhKaENrdUd4b2tLRFpMb3ZZSnhmcVI5U1BCbnJTcW83VG1STWd0NXdGVEZUT2NacVo5U2JiNkVOR043bw?oc=5","date":"2025-12-16","type":"pipeline","source":"Yahoo Finance","summary":"Oramed Pharmaceuticals And 2 Other Promising Penny Stocks To Watch - Yahoo Finance","headline":"Oramed Pharmaceuticals And 2 Other Promising Penny Stocks To Watch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQSTNfZVVueGtvNDBEMzZNREw2LTh4NGFpN2tEbjNERzZqWVNEbkhNRDlzN0QxbTVaaU1IODVmcGo5Y0FlOUZISTJzSk85SjJqMFYxQWQ5YWtQRi1UVlBTQndZZ3ZodTJwS2NjNjhfTHdjNVk1M1pDNW5adVJKLXNmMjVKSUJCSndlNW82LXRmYVE2dGFja3lEeDVuZHVEWTNnSF9DVGdvYkd1c2VSa1pwQ1ktaW9mN0RWMEJKcl9lbnpQcVhVeTNkdzhhRGtSU1R5ek14WDVXR2xQcXRoUVE?oc=5","date":"2025-11-17","type":"pipeline","source":"PR Newswire","summary":"ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS - PR Newswire","headline":"ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxNS2tZTzBWMHNoaGNuZUtIc1RJVWh4TmRmNmpSdmw3cmJiYUVZMlM0T1RqLS1IczBLdnpZSTFsLTFHaFZnWHphcDdfSThRTjREWFhqWndFTjFkenpCdDVYNFZHaG14YlR2TjUyUlRfeHRiZW1TdTlxMHJqX19ZSmJ0RzJITzBxdmFWeTFNN1FicDVFX1Qzemh3Tm9LSVZOeXF3ZThrM2JpM0psZ28xaXVVdmotMFZ6d1pmRnNqcDZabTFpQTNzblNRX2tXaWhDbmxXb2FJZUpFS1ctbEp2eUMxSWZpYXNDeEVtcjVBYWV2YmFOSW9SMDVwNjhIWmtjQjVxbk0xV3VDaEdVR0R0SGhsdWM0dEw4dV9sbFNyZlNyWHpuNjN4M0Z2T0VILV9jX1FjNVFNejIyY3FTcjNs?oc=5","date":"2025-10-23","type":"pipeline","source":"PR Newswire","summary":"Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives - PR Newswire","headline":"Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Ap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNQVJMc2Zlb01ZckNEdEJ4bUF6bFlmUldkRGgyVGpOQmNEWnpQX3EtWTA2Qm5iWjFTZzVzbDFheXo1amhaeUk3bnJxeWYyb2JJd040RmNTc3QyLUp2ZkFEcmpoRjJNVmNLUDBzc3dUc1ZqajhmSTVsaHh6SHhZMVV3cU12TWlxYm13cFZtOXlDWnVnRlhKZWRvQWZ6SDhldEtnXzR2ZG1oMGY3dHI5LTdiVzdtMksyX2NkSHpYSllPQ2xJQ1VLY0VWSEdZMk1Uc3FPRXdQX0NPZzdUX1NaUU5yTg?oc=5","date":"2025-10-01","type":"pipeline","source":"Quiver Quantitative","summary":"Scilex Holding Company Completes Repurchase of 3.13 Million Warrants from Oramed Pharmaceuticals for $13 Million - Quiver Quantitative","headline":"Scilex Holding Company Completes Repurchase of 3.13 Million Warrants from Oramed Pharmaceuticals for $13 Million","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}